Immutep Limited (IMMP) has a negative trailing P/E of -0.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 1.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -139.16%, forward earnings yield 93.46%.
Criteria proven by this page:
Overall SharesGrow Score: 47/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -10.0 | -0.28 | 17.49 | 3,528.05 | - |
| 2017 | -42.6 | 0.51 | 15.04 | 94.55 | - |
| 2018 | -35.9 | -4.40 | 13.64 | 173.76 | - |
| 2019 | -21.6 | 11.46 | 14.40 | 2,511.65 | - |
| 2020 | -15.8 | 0.54 | 6.38 | 28.37 | - |
| 2021 | -10.4 | -0.21 | 4.25 | 80.70 | - |
| 2022 | -7.9 | 0.32 | 2.70 | 1,488.23 | - |
| 2023 | -7.1 | -0.39 | 2.09 | 81.35 | - |
| 2024 | -8.5 | 0.43 | 1.91 | 94.24 | - |
| 2025 | -5.9 | -0.32 | 2.53 | 71.92 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-27.20 | $175.05K | $-62.02M | -35426.7% |
| 2017 | $-3.90 | $4.22M | $-9.37M | -221.9% |
| 2018 | $-4.60 | $2.63M | $-12.75M | -484.6% |
| 2019 | $-0.49 | $139.78K | $-16.27M | -11640% |
| 2020 | $-0.33 | $7.49M | $-13.47M | -179.9% |
| 2021 | $-0.49 | $3.97M | $-29.9M | -753.6% |
| 2022 | $-0.37 | $170.37K | $-32.21M | -18906.5% |
| 2023 | $-0.44 | $3.51M | $-39.9M | -1138% |
| 2024 | $-0.36 | $3.84M | $-42.72M | -1111.9% |
| 2025 | $-0.42 | $5.04M | $-61.43M | -1218% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.40 | $-0.74 – $-0.03 | $29.32M | $8.5M – $47.95M | 1 |
| 2027 | $-0.31 | $-0.58 – $-0.02 | $4.81M | $1.39M – $7.86M | 1 |
| 2028 | $-0.57 | $-1.04 – $-0.04 | $4.78M | $1.39M – $7.83M | 1 |
| 2029 | $-0.37 | $-0.67 – $-0.03 | $210.55M | $61.02M – $344.38M | 1 |
| 2030 | $0.51 | $0.04 – $0.93 | $987.33M | $286.15M – $1.61B | 1 |
